Regentis Biomaterials

GelrinC Overview

The most commonly used procedures for the repair of cartilage defects are microfracture, mosaicplasty, osteochondral autologous (or autograft) transplantation system (OATS), and Autologous Chondrocyte Implantation (ACI).

GelrinC is a completely novel treatment option. After standard microfracture, the hydrogel is injected as a liquid, conforming to the lesion size, shape and depth. No cutting or press fitting required to completely fill the lesion.
 
After short exposure to UVA light, the hydrogel becomes a semi-solid implant tightly integrated with the surrounding tissue and bone with no fibrin glue necessary to secure in place.
 
The implant acts as a scaffold, gradually eroding over time as new cartilage takes its place. The GelrinC implant completely degrades within 6-12 months.
 
Indication 

GelrinC is intended for the repair of focal defects in cartilage and/or osteochondral defects.

Caution: Investigational Device. Limited by U.S. law to investigational use.